已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Frequency and risk factors of antibody-induced secondary failure of botulinum neurotoxin therapy

医学 内科学 累积发病率 回顾性队列研究 肉毒毒素 队列 外科
作者
Uwe Walter,Christopher Mühlenhoff,Reiner Benecke,Dirk Dressler,Eilhard Mix,Janes Alt,Matthias Wittstock,Aleš Dudešek,Alexander Storch,Christoph Kamm
出处
期刊:Neurology [Lippincott Williams & Wilkins]
卷期号:94 (20) 被引量:40
标识
DOI:10.1212/wnl.0000000000009444
摘要

Objective

To investigate the risk factors of neutralizing antibody (NAB)–induced complete secondary treatment failure (cSTF) during long-term botulinum neurotoxin (BoNT) treatment in various neurologic indications.

Methods

This monocenter retrospective cohort study analyzed the data of 471 patients started on BoNT therapy between 1995 and 2015. Blood samples of 173 patients were investigated for NABs using the mouse hemidiaphragm test (93 with suspected therapy failure, 80 prospective study participants). The frequency of NAB-cSTF was assessed for various indications: hemifacial spasm, blepharospasm, cervical dystonia, other dystonia, and spasticity. A priori defined potential risk factors for NAB-cSTF were evaluated, and a stepwise binary logistic regression analysis was performed to identify independent risk factors.

Results

Treatment duration was 9.8 ± 6.2 years (range, 0.5–30 years; adherence, 70.6%) and number of treatment cycles 31.2 ± 22.5 (3–112). Twenty-eight of 471 patients (5.9%) had NAB-cSTF at earliest after 3 and at latest after 103 treatment cycles. None of the 49 patients treated exclusively with incobotulinumtoxinA over 8.4 ± 4.2 (1–14) years developed NAB-cSTF. Independent risk factors for NAB-cSTF were high BoNT dose per treatment, switching between onabotulinumtoxinA and other BoNT formulations (except for switching to incobotulinumtoxinA), and treatment of neck muscles.

Conclusions

We present a follow-up study with the longest duration to date on the incidence of NAB-cSTF in patients treated with various BoNT formulations, including incobotulinumtoxinA. Whereas the overall risk of NAB-cSTF is low across indications and BoNT formulations, our findings underpin the recommendations to use the lowest possible dose particularly in cervical dystonia, and to avoid unnecessary switching between different formulations.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
orixero应助momo采纳,获得10
2秒前
kk完成签到,获得积分10
2秒前
4秒前
4秒前
昏睡的傲菡完成签到 ,获得积分10
5秒前
Bob关闭了Bob文献求助
7秒前
8秒前
喽喽发布了新的文献求助10
8秒前
一直向前发布了新的文献求助10
8秒前
11秒前
淡然如风完成签到,获得积分10
12秒前
12秒前
前行者发布了新的文献求助10
13秒前
13秒前
13秒前
淡然如风发布了新的文献求助10
15秒前
豆包发布了新的文献求助10
17秒前
17秒前
围炉夜话完成签到,获得积分10
18秒前
18秒前
张二发布了新的文献求助10
18秒前
Jasper应助科研通管家采纳,获得10
19秒前
在水一方应助科研通管家采纳,获得10
19秒前
coolkid应助科研通管家采纳,获得10
19秒前
20秒前
乐乐应助科研通管家采纳,获得10
20秒前
20秒前
Owen应助科研通管家采纳,获得10
20秒前
20秒前
深情安青应助科研通管家采纳,获得10
20秒前
充电宝应助科研通管家采纳,获得10
20秒前
充电宝应助科研通管家采纳,获得10
20秒前
cf2v发布了新的文献求助10
22秒前
积极的香菇完成签到 ,获得积分10
22秒前
26秒前
所所应助bulinggu采纳,获得10
26秒前
28秒前
sky完成签到,获得积分10
29秒前
31秒前
niuma发布了新的文献求助20
34秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989832
求助须知:如何正确求助?哪些是违规求助? 3531967
关于积分的说明 11255613
捐赠科研通 3270725
什么是DOI,文献DOI怎么找? 1805035
邀请新用户注册赠送积分活动 882181
科研通“疑难数据库(出版商)”最低求助积分说明 809208